Dr. Rick Strassman

Biopharma company Algernon Pharmaceuticals Inc's (OTC: AGNPF) recently announced plan for a Phase 1 clinical study on DMT for human stroke has just received approval from the Stichting Beoordeling Ethiek Biomedisch Onderzoek (BEBO), an independent Medical Research Ethics Committee....

Last Week In Psychedelics: CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs Octarine Bio and Clerkenwell Health Partner Up For Clinical Trials Mydecine To Launch Smoking Cessation Clinical Trial With Johns Hopkins University DMT Found To Stimulate Growth Of...

This article was originally published on WeedWeek, and appears here with permission. Oregon’s recent vote to legalize psilocybin therapy, and the IPO of pharmaceutial psilocybin company Compass Pathways are just the latest signs of surging interest and newfound...